“…Deficits in response inhibition control are related to many diseases, such as attention deficit hyperactivity disorder (ADHD) ( Smith et al, 2004 ; van Hulst et al, 2018 ; Suarez et al, 2021 ), posttraumatic stress disorder (PTSD) ( Shucard et al, 2008 ), depression ( Kaiser et al, 2003 ), obsessive-compulsive disorder (OCD) and Tourette syndrome (TS) ( Mancini et al, 2018 ), primary motor stereotypies ( Mirabella et al, 2020 ), autism spectrum disorders (ASD) ( Schmitt et al, 2018 ), and Parkinson’s disease (PD) ( Bokura et al, 2005 ; Mirabella et al, 2017 ; di Caprio et al, 2020 ). The amplitudes of NoGo-N2 and NoGo-P3 were also significantly smaller in the PD group than in the control group ( Bokura et al, 2005 ).…”